CTRI/2022/06/043126招募中2 期
A Multi-centre Open label Phase II clinical trial to compare the effectiveness and safety of local anaesthesia by polyherbal local anesthetic injection and lignocaine hydrochloride in minor surgical procedures
Pankajakasthuri Herbals India Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Subjects indicated for minor surgical procedures under Local anaesthesia; Willing to enroll in the study by signing the informed consent.
排除标准
- •1. Hypersensitivity to any one of the ingredients in the polyherbal local anaesthetic injection, lignocaine hydrochloride or to any local anaesthetic agent of amide type.
- •2. Uncontrolled hypertension/congenital heart problems.
- •3. Any chronic illness with life-threatening comorbidities.
- •4. Impaired cardiovascular and respiratory function.
- •5. Patients with medicament-induced altered pain perception.
研究者
相似试验
进行中（未招募）
不适用
An Open Label Phase II Multicentre Clinical Trial of Single Agent VELCADE (Bortezomib) in Patients with Malignant Pleural Mesothelioma - Phase II Velcade Mesothelioma trialMalignant Pleural Mesothelioma (in first line, and second line treatment settings)EUCTR2005-004420-39-IEAll-Ireland Co-operative Oncology Research Group (ICORG)111
已完成
2 期
An Open Label Phase II Multicentre Clinical Trial of Single Agent VELCADETM (Bortezomib) in Patients with Malignant Pleural Mesotheliomapleural cancermesothelioma10027412NL-OMON30139All Ireland Cooperative Oncology Research Group8
进行中（未招募）
1 期
An Open Label Phase II Multicentre Clinical Trial of Single Agent VELCADE (Bortezomib) in Patients with Malignant Pleural Mesothelioma - Phase II Velcade Mesothelioma trialEUCTR2005-004420-39-GBAll-Ireland Co-operative Oncology Research Group (ICORG)111
进行中（未招募）
不适用
An Open Label Phase II Multicentre Clinical Trial of Single Agent VELCADE (Bortezomib) in Patients with Malignant Pleural Mesothelioma - Phase II Velcade Mesothelioma trialEUCTR2005-004420-39-BEniversity Hospital Gent136
进行中（未招募）
不适用
An Open Label Phase II Multicentre Clinical Trial of Single Agent VELCADE (Bortezomib) in Patients with Malignant Pleural Mesothelioma - Phase II Velcade Mesothelioma trialMalignant Pleural Mesothelioma (in first line, and second line treatment settings)EUCTR2005-004420-39-NLAll-Ireland Co-operative Oncology Research Group (ICORG)111